Fraunhofer Institute for Biomedical Engineering

The Fraunhofer Institute for Biomedical Engineering IBMT acts as a device and technology developer when it comes to the solution of individual research and development projects and tasks from the areas of biomedical/medical engineering, medical (molecular and cellular) biotechnology, biohybrid technology, bioprocessing & bioanalytics, cryo(bio)technology and nano(bio)technology, ultrasound technology, biomedical microsystems, neuroprosthetics and implants, health information systems, theranostics, (mobile) laboratory technology as well as laboratory automation including in-line/on-line process control. For more than 10 years, Fraunhofer IBMT has been working in the field of stem cell research and hosting extensive cell line stocks in industrial and clinically structured biobanks for low temperature storage of valuable samples (fluids, cells, tissue fragments).

360° tour - A virtual tour through laboratories and premises of the Fraunhofer IBMT at Sulzbach

Core Competences

Research and Development


Stem Cell & Cryo Technology


Bioprocessing & Bioanalytics




Biomedical Engineering


Fraunhofer Project Center for Stem Cell Process Engineering


Environmental Specimen Bank - Human Samples


Fraunhofer Center for Sensor Intelligence ZSI

Current Topics



Development of a miniaturized lung and kidney support device for critically ill newborns

Fraunhofer IBMT Partner in the EU Project "ArtPlac"



Bidirectional control of prosthetic hands using ultrasonic sensors

Fraunhofer IBMT in the EU-Project SOMA - Neuroprostetics



Development and validation of a software platform for the prevention, detection and analysis of cyberattacks in the healthcare sector

Fraunhofer IBMT Partner in the EU Project "AI4HealthSec"



Human-machine interface stops muscle tremors

Neuromedicine - Fraunhofer Institute for Biomedical Engineering IBMT Partner in the  EU Joint Project EXTEND



A new EBiSC iPSC-derived neuronal cell product simplifies neuroscience research

The European Bank for induced Pluripotent Stem Cells (EBiSC) is happy to announce a new iPSC derived neuronal cell product - EBiSC-NEUR1 which can be used directly from thaw for downstream applications.


A new generation of microimplants

A new generation of interactive microimplants developed by the innovation cluster INTAKT, which is funded by the German Federal Ministry of Education and Research (BMBF) and coordinated by the Fraunhofer Institute for Biomedical Engineering IBMT helps as miniature assistants to stimulate in cases of tinnitus or digestive tract disorders or helps a person’s hand to regain the ability to grip.




Fraunhofer at MEDICA/COMPAMED 2022

BioSensoLab - Biological laboratory to go

Researchers from the Fraunhofer Institute for Biomedical Engineering IBMT have developed the “BioSensoLab“, a mobile biological laboratory with which they can demonstrate new developments to customers and test them together – on site at their companies.


Fraunhofer IBMT in EC-Horizon 2020 - FET Open Project GLADIATOR

New technologies for cancer monitoring and therapy
A transdisciplinary, paradigm-shifting, approach with bio-nanodevice interfaces


Fraunhofer IBMT is part of the European Partnership for the Assessment of Risks from Chemicals (PARC)

Next-generation chemical risk assessment




Fraunhofer IBMT Partner in the new EU Project “SafePolyMed”

Safer Drug Treatment and Enhanced Patient Empowerment




Human cell-based test systems for toxicity studies

R2U-Tox-Assay - Ready-to-use Toxicity Screening Assay based on iPS-Technologies



EBiSC2 and FAIRplus are improving FAIRness of stem cell data

The FAIRplus and EBiSC2 projects are joining forces to improve how ‘FAIR’ standards (Findability, Accessibility, Interoperability and Reusability) can be applied to human induced Pluripotent Stem Cell (iPSC) line data.




Headquarters Sulzbach (Saarland)

Site St. Ingbert (Saarland)

Project Center Stem Cell Process Engineering Würzburg (Bavaria)

Branch Münster/Wolbeck (North Rhine-Westphalia)

Liaison Office Berlin (Berlin)